Extension protects entrenched board and management rather than maximizesshareholder value; shareholders must demand an immediate vote. CHICAGO , Nov. 7, 2025 /PRNewswire/ -- Edward and Ludmila Smolyansky, long-term shareholders of Lifeway Foods, Inc. (NASDAQ: LWAY ) who together exercise voting control with respect to approximately 26% of the outstanding shares of Lifeway Foods today provided a response to the Company's extension of its existing Shareholder Rights Agreement (the "Rights Plan") as well as an update on the upcoming Lifeway Foods 2025 election.

image for news Edward Smolyansky Issues Statement Regarding Lifeway Foods (NASDAQ: LWAY) Extension of Existing Rights Plan, Board Refreshment and Delayed 2025 Annual Meeting

Nebius: The Hype Overwhelms Sobriety (Upgrade) — Positive

NBIS   Seeking Alpha — November 07, 2025

Nebius Group N.V. has surged over 100% since July, but this rally is not supported by improved fundamentals or profitability outlook. Despite a 30% increase in revenue estimates, NBIS's EPS forecasts have declined, raising concerns about its business model and valuation. NBIS stock's forward P/S ratio has soared to 51, making the current $27 billion market cap appear unjustified by near-term growth potential.

image for news Nebius: The Hype Overwhelms Sobriety (Upgrade)

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Savara To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Savara between March 7, 2024 and May 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Nov. 7, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Savara Inc. ("Savara" or the "Company") …

image for news FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara

EOG Resources' Q3 Earnings Beat Estimates on Production — Positive

EOG   Zacks Investment Research — November 07, 2025

EOG posts Q3 EPS of $2.71, topping estimates on strong output growth, though lower price realization weighs on revenue.

image for news EOG Resources' Q3 Earnings Beat Estimates on Production

Waste Management: The Garbage Collector AI Can't Replace — Positive

WM   Seeking Alpha — November 07, 2025

Waste Management stands as the dominant U.S. waste services provider, boasting a resilient, AI-resistant business model and a powerful regulatory moat. Despite a recent earnings double-miss and a 20% stock pullback, WM offers a compelling entry point, trading at a discount to historical and peer valuations. Strategic investments in recycling, renewable energy, and healthcare waste position WM for durable growth, with cost synergies from the Stericycle acquisition enhancing profitability.

image for news Waste Management: The Garbage Collector AI Can't Replace

LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against RCI Hospitality Holdings, Inc. (“RCI” or “the Company”) (NASDAQ: RICK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between December 15, 2021 and September 16, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before November 20, 2025.

image for news RICK Investors Have Opportunity to Lead RCI Hospitality Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

DraftKings Q3 revenue misses, lowers guidance as user growth slows — Negative

DKNG   Proactive Investors — November 07, 2025

Draftkings Inc (NASDAQ:DKNG) late Thursday reported third quarter 2025 revenue that rose 4% year over year to $1.14 billion, falling short of the analyst consensus estimate of $1.2 billion. The sports betting platform, though, posted a loss for the period of $0.26 per share, better than expectations of a $0.32 per share deficit.

image for news DraftKings Q3 revenue misses, lowers guidance as user growth slows

Cmb.Tech: Still Some Juice Left — Positive

CMBT   Seeking Alpha — November 07, 2025

Cmb.Tech NV trades at a significant discount to NAV, offering an attractive entry point for investors. Recent Golden Ocean acquisition and messy financials obscure strong Q3/Q4 earnings potential, with consensus estimates likely to be beaten. CMBT benefits from a young, diversified fleet, high time-charter coverage, and exposure to strong dry bulk and tanker markets.

image for news Cmb.Tech: Still Some Juice Left

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Quanex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Quanex between December 12, 2024 and September 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 7, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Quanex Building Products Corporation …

image for news SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Quanex Building Products

Expensify, Inc. (EXFY) Q3 2025 Earnings Call Transcript — Neutral

EXFY   Seeking Alpha — November 07, 2025

Expensify, Inc. ( EXFY ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Ryan Schaffer - CFO & Director Niki Wallroth David Barrett - Founder, CEO, President & Director Conference Call Participants George Michael Kurosawa - Citigroup Inc., Research Division Aaron Kimson - Citizens JMP Securities, LLC, Research Division Presentation Ryan Schaffer CFO & Director Welcome to the Expensify Q3 2025 Earnings. I'm CFO, Ryan Schaffer.

image for news Expensify, Inc. (EXFY) Q3 2025 Earnings Call Transcript

Vermilion Energy Inc. (VET:CA) Q3 2025 Earnings Call Transcript — Neutral

VET   Seeking Alpha — November 07, 2025

Vermilion Energy Inc. ( VET:CA ) Q3 2025 Earnings Call November 6, 2025 11:00 AM EST Company Participants Anthony Hatcher - President, CEO & Director Lars Glemser - VP & CFO Travis Thorgeirson Darcy Kerwin Lee Ernest McQuaig - Vice President of North America Conference Call Participants Travis Wood - National Bank Financial, Inc., Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Vermilion Energy Q3 2025 Conference Call. [Operator Instructions] This call is being recorded on Thursday, November 6, 2025.

image for news Vermilion Energy Inc. (VET:CA) Q3 2025 Earnings Call Transcript

Celanese Q3 Earnings Surpass Estimates Amid Lower Sales Volumes — Neutral

CE   Zacks Investment Research — November 07, 2025

CE posts sharp earnings fall but tops estimates, with cost cuts and strong cash flow guiding its 2025 outlook.

image for news Celanese Q3 Earnings Surpass Estimates Amid Lower Sales Volumes

GeoPark Limited (GPRK) Q3 2025 Earnings Call Transcript — Neutral

GPRK   Seeking Alpha — November 07, 2025

GeoPark Limited ( GPRK ) Q3 2025 Earnings Call November 6, 2025 10:00 AM EST Company Participants Felipe Bayon Pardo - CEO & Director Rodolfo Terrado - Chief Operating Officer Jaime Caballero Uribe - Chief Financial Officer Rodrigo Fiore - Chief Exploration & Development Officer Rodrigo Dalle Fiore Conference Call Participants Joaquin Robet Stephane Guy Foucaud - Auctus Advisors LLP, Research Division Daniel Guardiola - Banco BTG Pactual S.A., Research Division Isabella Pacheco - BofA Securities, Research Division Alejandro Anibal Demichelis - Jefferies LLC, Research Division Presentation Operator Good morning and welcome to the GeoPark Limited conference call following the …

image for news GeoPark Limited (GPRK) Q3 2025 Earnings Call Transcript

Algonquin Power & Utilities (AQN) Beats Q3 Earnings Estimates — Positive

AQN   Zacks Investment Research — November 07, 2025

Algonquin Power & Utilities (AQN) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.08 per share a year ago.

image for news Algonquin Power & Utilities (AQN) Beats Q3 Earnings Estimates

Koppers (KOP) Misses Q3 Earnings and Revenue Estimates — Negative

KOP   Zacks Investment Research — November 07, 2025

Koppers (KOP) came out with quarterly earnings of $1.21 per share, missing the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.37 per share a year ago.

image for news Koppers (KOP) Misses Q3 Earnings and Revenue Estimates

Today's Market Moving Stocks: Affirm Holdings, Expedia, and Globus Medical — Neutral

AFRM  EXPE  GMED   24/7 Wall Street — November 07, 2025

The image featured for this article is © Thinkstock

image for news Today's Market Moving Stocks: Affirm Holdings, Expedia, and Globus Medical

SLNO Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO , Nov. 7, 2025 /PRNewswire/ -- On November 5, 2025, investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) saw the price of their shares tumble $18.78 (-28%) after the company reported disappointing information about VYKAT™ XR, a once-daily oral tablet intended to treat hyperphagia. Soleno has described this condition as "the most life-limiting aspect" of Prader-Willi syndrome, a rare genetic disorder that causes physical, mental, and behavioral problems.

image for news Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKATÔ XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman

NEW YORK , Nov. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO ) (the "Company" or "Klotho"), a U.S.-based biogenetics company, announces it has been selected as winner of the Fifth Annual BioTech Breakthrough Award in the "Cell Therapy Innovation of the Year" category. Klotho Neurosciences earned this recognition for its pioneering work developing transformative gene and cell therapies using a patented, secreted form of the human Klotho gene (s-KL) to address devastating neurodegenerative and age-related diseases, including ALS, Alzheimer's disease, and Parkinson's disease.

image for news Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award

LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against V.F. Corporation (“VF” or “the Company”) (NYSE: VFC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

image for news V.F. Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – VFC

Ecopetrol S.A. (EC) is Attracting Investor Attention: Here is What You Should Know — Positive

EC   Zacks Investment Research — November 07, 2025

Recently, Zacks.com users have been paying close attention to Ecopetrol (EC). This makes it worthwhile to examine what the stock has in store.

image for news Ecopetrol S.A. (EC) is Attracting Investor Attention: Here is What You Should Know